Oral Echinacea purpurea Extract in Low-Grade, Steroid-Dependent, Autoimmune Idiopathic Uveitis: A Pilot Study
- 1 December 2006
- journal article
- clinical trial
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 22 (6) , 431-436
Abstract
The aim of to test efficacy and safety of Echinacea purpurea (echinacea) extract in the control of low-grade uveitis. Fifty-one (51) patients with low-grade, steroid dependent, autoimmune uveitis were recruited; posterior uveitis was excluded. The start therapy was represented by topical desamethazone for anterior uveitis and oral prednisone, rapidly tapered, for anterior uveitis with inflammatory scores equal to +2 and in all cases of intermediate uveitis. Best-corrected visual acuity (BCVA) decrease or improvement was defined as a reduction or increase of 2 or more letters seen from the initial BCVA; ETDRS chart was used. Thirty-two (32) patients (21 with anterior uveitis and 11 with intermediate uveitis) received Echinacea (150 mg twice/day) as add-on therapy, whereas 20 patients (10 with anterior uveitis and 9 with intermediate uveitis) were treated with the conventional steroid therapy alone. Thirty-one (31) patients showed anterior uveitis and 20 intermediate uveitis. The follow-up duration was 9 months. At the last follow-up, 19/21 patients with anterior uveitis and 9/11 with intermediate uveitis treated with echinacea presented uveitis settled, with a steroid-off time of 209 and 146 days, respectively. BCVA was stable or improved in 19/21 of anterior uveitis and 9/11 of intermediate uveitis. No adverse reactions supposed to be resulting from commercial-grade echinacea were recorded. Patients who did not receive echinacea required a longer treatment period with steroids with a steroid-off time of 121 and 87 days. Systemic echinacea appears safe and effective in the control of low-grade autoimmune idiopathic uveitis.Keywords
This publication has 14 references indexed in Scilit:
- Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitisRheumatology International, 2003
- Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitisBritish Journal of Ophthalmology, 2003
- Ocular complications of topical, peri-ocular, and systemic corticosteroidsCurrent Opinion in Ophthalmology, 2000
- Mycophenolate mofetilOphthalmology, 1999
- Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitisOcular Immunology and Inflammation, 1998
- Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin ABritish Journal of Ophthalmology, 1997
- Treatment of Persistent Glaucoma Secondary to Periocular CorticosteroidsAmerican Journal of Ophthalmology, 1996
- In VitroInhibition of Cyclooxygenase and 5-Lipoxygenase by Alkamides fromEchinaceaandAchilleaSpeciesPlanta Medica, 1994
- Treatment of autoimmune uveoretinitis in the rat with rapamycin, an inhibitor of lymphocyte growth factor signal transductionCurrent Eye Research, 1993
- Evidence from two classic irritation tests for an anti-inflammatory action of a natural extract, Echinacina BFood and Chemical Toxicology, 1985